686 related articles for article (PubMed ID: 34343496)
21. A bacterial flagellin in combination with proinflammatory cytokines activates human monocyte-derived dendritic cells to generate cytotoxic T lymphocytes having increased homing signals to cancer.
Hong CY; Kim SY; Lee HJ; Lee SE; Lim SC; Rhee JH; Lee JJ
J Immunother; 2014 Jan; 37(1):16-25. PubMed ID: 24316552
[TBL] [Abstract][Full Text] [Related]
22. Dendritic cells activated by an anti-inflammatory agent induce CD4(+) T helper type 2 responses without impairing CD8(+) memory and effector cytotoxic T-lymphocyte responses.
Wang Y; Da'Dara AA; Thomas PG; Harn DA
Immunology; 2010 Mar; 129(3):406-17. PubMed ID: 19922421
[TBL] [Abstract][Full Text] [Related]
23. CXCL16/CXCR6 is involved in LPS-induced acute lung injury via P38 signalling.
Tu GW; Ju MJ; Zheng YJ; Hao GW; Ma GG; Hou JY; Zhang XP; Luo Z; Lu LM
J Cell Mol Med; 2019 Aug; 23(8):5380-5389. PubMed ID: 31199046
[TBL] [Abstract][Full Text] [Related]
24. In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models.
Oba T; Makino K; Kajihara R; Yokoi T; Araki R; Abe M; Minderman H; Chang AE; Odunsi K; Ito F
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34049930
[TBL] [Abstract][Full Text] [Related]
25. Tumor-specific cytotoxic T cell generation and dendritic cell function are differentially regulated by interleukin 27 during development of anti-tumor immunity.
Shinozaki Y; Wang S; Miyazaki Y; Miyazaki K; Yamada H; Yoshikai Y; Hara H; Yoshida H
Int J Cancer; 2009 Mar; 124(6):1372-8. PubMed ID: 19089917
[TBL] [Abstract][Full Text] [Related]
26. CXCL16 Stimulates Antigen-Induced MAIT Cell Accumulation but Trafficking During Lung Infection Is CXCR6-Independent.
Yu H; Yang A; Liu L; Mak JYW; Fairlie DP; Cowley S
Front Immunol; 2020; 11():1773. PubMed ID: 32849637
[TBL] [Abstract][Full Text] [Related]
27. Cxcr6-Based Mesenchymal Stem Cell Gene Therapy Potentiates Skin Regeneration in Murine Diabetic Wounds.
Dhoke NR; Kaushik K; Das A
Mol Ther; 2020 May; 28(5):1314-1326. PubMed ID: 32112713
[TBL] [Abstract][Full Text] [Related]
28. CXCR6 defines therapeutic subtypes of CD4
Shi S; Xing H; Xu X; Chai J; Lu Z; Wang J; Wang B
Int Immunopharmacol; 2024 May; 132():111972. PubMed ID: 38569429
[TBL] [Abstract][Full Text] [Related]
29. Type 1 Conventional CD103
Ng SL; Teo YJ; Setiagani YA; Karjalainen K; Ruedl C
Front Immunol; 2018; 9():3043. PubMed ID: 30622538
[TBL] [Abstract][Full Text] [Related]
30. Lymphocyte-polarized dendritic cells are highly effective in inducing tumor-specific CTLs.
Berk E; Muthuswamy R; Kalinski P
Vaccine; 2012 Sep; 30(43):6216-24. PubMed ID: 22561311
[TBL] [Abstract][Full Text] [Related]
31. Activation of the CXCL16/CXCR6 Axis by TNF-α Contributes to Ectopic Endometrial Stromal Cells Migration and Invasion.
Peng Y; Ma J; Lin J
Reprod Sci; 2019 Mar; 26(3):420-427. PubMed ID: 29779473
[TBL] [Abstract][Full Text] [Related]
32. CD8
Farhood B; Najafi M; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
[TBL] [Abstract][Full Text] [Related]
33. Human gingival fibroblasts express functional chemokine receptor CXCR6.
Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
Clin Exp Immunol; 2009 Jun; 156(3):413-8. PubMed ID: 19438592
[TBL] [Abstract][Full Text] [Related]
34. Immature renal dendritic cells recruit regulatory CXCR6(+) invariant natural killer T cells to attenuate crescentic GN.
Riedel JH; Paust HJ; Turner JE; Tittel AP; Krebs C; Disteldorf E; Wegscheid C; Tiegs G; Velden J; Mittrücker HW; Garbi N; Stahl RA; Steinmetz OM; Kurts C; Panzer U
J Am Soc Nephrol; 2012 Dec; 23(12):1987-2000. PubMed ID: 23138484
[TBL] [Abstract][Full Text] [Related]
35. The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers.
Darash-Yahana M; Gillespie JW; Hewitt SM; Chen YY; Maeda S; Stein I; Singh SP; Bedolla RB; Peled A; Troyer DA; Pikarsky E; Karin M; Farber JM
PLoS One; 2009 Aug; 4(8):e6695. PubMed ID: 19690611
[TBL] [Abstract][Full Text] [Related]
36. CXCR6: the role of environment in tumor progression. Challenges for therapy.
La Porta CA
Stem Cell Rev Rep; 2012 Dec; 8(4):1282-5. PubMed ID: 22678828
[TBL] [Abstract][Full Text] [Related]
37. Tumor-associated macrophages promote the metastasis of ovarian carcinoma cells by enhancing CXCL16/CXCR6 expression.
Hong L; Wang S; Li W; Wu D; Chen W
Pathol Res Pract; 2018 Sep; 214(9):1345-1351. PubMed ID: 30049511
[TBL] [Abstract][Full Text] [Related]
38. CXCR6 is required for antitumor efficacy of intratumoral CD8
Wang B; Wang Y; Sun X; Deng G; Huang W; Wu X; Gu Y; Tian Z; Fan Z; Xu Q; Chen H; Sun Y
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34462326
[TBL] [Abstract][Full Text] [Related]
39. Helper activity of natural killer cells during the dendritic cell-mediated induction of melanoma-specific cytotoxic T cells.
Wong JL; Mailliard RB; Moschos SJ; Edington H; Lotze MT; Kirkwood JM; Kalinski P
J Immunother; 2011 Apr; 34(3):270-8. PubMed ID: 21389871
[TBL] [Abstract][Full Text] [Related]
40. Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-kappa B (RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigen.
Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
J Immunol; 2003 Oct; 171(8):4121-30. PubMed ID: 14530334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
